. 2017 Apr 28;3:155–159. doi: 10.1016/j.pvr.2017.04.005

Table 1.

Agreement between assays, instruments and sample types.

Assay sample type		AHPV Assay Tigris ATS-treated SurePath			Agreement % (x/n)			Kappa statistic
Assay sample type		+	-	Total	Positive	Negative	Overall	Kappa statistic
AHPV Assay Panther ATS-treated SurePath	+	577	25	602	94.4%	96.5%	95.5%	0.91
	–	34	689	723	94.4%	96.5%	95.5%
	Total	611	714	1325	(577/611)	(689/714)	(1266/1325)
AHPV Assay Tigris PreservCyt	+	552	51	603	88.9%	93.0%	91.1%	0.81
	–	69	673	742	88.9%	93.0%	91.1%
	Total	621	724	1345	(552/621)	(673/724)	1225/1345)
Cobas HPV Test SurePath	+	585	99	684	93.9%	86.4%	89.9%	0.80
	–	38	628	666	93.9%	86.4%	89.9%
	Total	623	727	1350	(585/623)	(628/727)	(1213/1350)